Funds and ETFs TaiGen Biopharmaceuticals Holdings Limited

Equities

4157

KYG866171005

Biotechnology & Medical Research

End-of-day quote Taipei Exchange 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
15.4 TWD -0.65% Intraday chart for TaiGen Biopharmaceuticals Holdings Limited -6.38% +1.32%

ETFs positioned on TaiGen Biopharmaceuticals Holdings Limited

Name Weight AuM 1st Jan change Investor Rating
0.00% 4 M€ -4.41% -
0.00% 34 M€ +2.14% -
TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED is a Taiwan-based company principally engaged in the research and production of pharmaceutical products. The Company's products mainly are new chemical entities (NCEs) in infectious diseases, cancer and diabetes-related complications. Its products include Nemonoxacin, Burlxafor and TG-2349. The Company receives its revenue mainly from the authorization of Nemonoxacin products.
More about the company
  1. Stock Market
  2. Equities
  3. 4157 Stock
  4. Funds and ETFs TaiGen Biopharmaceuticals Holdings Limited